Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totaling 1,880 shares, a drop of 93.9% from the May 31st total of 30,585 shares. Based on an average trading volume of 124,355 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold.
Analysts Set New Price Targets
SAUHY has been the topic of a number of recent research reports. Citigroup reissued a “sell” rating on shares of Straumann in a report on Thursday, April 23rd. Barclays reaffirmed an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Finally, Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on Straumann
Straumann Stock Performance
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Featured Articles
- Five stocks we like better than Straumann
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
